Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Maderer · SciRah

Researcher profile · Semantic Scholar

A. Maderer

Share profile

A. Maderer — researcher profile on SciRah

h-index: 15
Works: 47
Citations: 864

Most-cited papers

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.
M. Moehler, A. Maderer, C. Schimanski, S. Kanzler +21 more
2014European Journal of Cancer132 citations Open access
Semantic Scholar
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).
M. Moehler, A. Maderer, P. Thuss-Patience, B. Brenner +16 more
2020Annals of Oncology109 citations Open access
Semantic Scholar
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
M. Michel, L. Kaps, A. Maderer, P. Galle +1 more
2021Cancers104 citations Open access
Semantic Scholar
Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.
H. Lang, J. Baumgart, S. Heinrich, V. Tripke +6 more
2019Annals of Surgery71 citations
Semantic Scholar
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program
M. Moehler, Irina Gepfner-Tuma, A. Maderer, P. Thuss-Patience +17 more
2016BMC Cancer65 citations Open access
Semantic Scholar
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801).
M. Stahl, A. Maderer, F. Lordick, A. Mihaljevic +12 more
2018European Journal of Cancer38 citations Open access
Semantic Scholar
Novel 3-Azaindolyl-4-arylmaleimides exhibiting potent antiangiogenic efficacy, protein kinase inhibition, and antiproliferative activity.
C. Ganser, Eva Lauermann, A. Maderer, T. Stauder +5 more
2012Journal of Medicinal Chemistry34 citations Open access
Semantic Scholar
Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program
M. Moehler, A. Maderer, Anne Ehrlich, Friedrich Foerster +9 more
2019BMC Cancer33 citations Open access
Semantic Scholar
Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?
A. Moore, E. Hikri, T. Goshen-Lago, Tamar Barkan +9 more
2020BMC Cancer32 citations Open access
Semantic Scholar
How we launched a developmental student-as-teacher (SAT) program for all medical students
M. Blanco, A. Maderer, Amanda Oriel, S. Epstein
2014Medical Teacher31 citations
Semantic Scholar
Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy
T. Wehler, S. Hamdi, A. Maderer, C. Graf +8 more
2012International Journal of Colorectal Disease28 citations Open access
Semantic Scholar
Efficiency is not enough; you have to prove that you care: role modelling of compassionate care in an innovative resident-as-teacher initiative.
M. Blanco, A. Maderer, L. Price, S. Epstein +1 more
2013Education and Health22 citations
Semantic Scholar
Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patients
A. Haupts, A. Vogel, S. Foersch, Monika Hartmann +8 more
2021Scientific Reports21 citations Open access
Semantic Scholar
Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial
T. Thomaidis, A. Maderer, A. Formentini, S. Bauer +12 more
2014Journal of experimental & clinical cancer research : CR21 citations Open access
Semantic Scholar
Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)
M. Moehler, A. Schad, A. Maderer, A. Atasoy +9 more
2018Cancer Chemotherapy and Pharmacology16 citations
Semantic Scholar
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial
M. Nagel, J. Schulz, A. Maderer, K. Goepfert +9 more
2018Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine14 citations Open access
Semantic Scholar
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3)
Markus Moehler, G. Folprecht, V. Heinemann, J. Holch +18 more
2021International Journal of Cancer12 citations Open access
Semantic Scholar
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)
D. Rades, T. Bartscht, P. Hunold, H. Schmidberger +15 more
2020Strahlentherapie und Onkologie (Print)11 citations Open access
Semantic Scholar
Tu1476 – Afatinib Combined with Gemcitabine/Cisplatin in Chemotherapy Naive Patients with Advanced Biliary Tract Cancer: Results and Translational Analysis of an Open-Label, Phase I Trial
T. Thomaidis, A. Maderer, A. Schad, C. Ruckes +7 more
2019Gastroenterology11 citations Open access
Semantic Scholar
Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!
M. Moehler, T. Thomaidis, Chourouk Zeifri, T. Barhoom +10 more
2015Journal of Cancer Research and Clinical Oncology11 citations Open access
Semantic Scholar
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
M. Ledenko, S. Antwi, S. Arima, Julia Driscoll +16 more
2022Frontiers in Oncology10 citations Open access
Semantic Scholar
Collagen turnover biomarkers to predict outcome of patients with biliary cancer
L. Kaps, M. A. Genc, M. Moehler, S. Grabbe +7 more
2025BMC Gastroenterology8 citations Open access
Semantic Scholar
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
T. Thomaidis, A. Maderer, S. Al-Batran, J. Kany +8 more
2014BMC Cancer8 citations Open access
Semantic Scholar
Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases
A. Desuki, F. Staib, I. Gockel, M. Moehler +6 more
2019Canadian Journal of Gastroenterology and Hepatology6 citations Open access
Semantic Scholar
Moguntinones—New Selective Inhibitors for the Treatment of Human Colorectal Cancer
A. Maderer, S. Plutizki, Jan-Peter Kramb, K. Göpfert +7 more
2014Molecular Cancer Therapeutics5 citations
Semantic Scholar
Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer.
D. Rades, A. Maderer, A. Panzner, P. Hunold +3 more
2017Anticancer Research3 citations Open access
Semantic Scholar
Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker program.
M. Moehler, A. Maderer, P. Thuss-Patience, B. Brenner +17 more
2018Annals of Oncology2 citations Open access
Semantic Scholar
Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer
L. Kaps, M. A. Genc, M. Möhler, Stephan Grabbe +8 more
2026Cancer Biomarkers1 citations Open access
Semantic Scholar
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset
A. Maderer, F. Fiteni, E. Tanis, M. Mauer +9 more
2021Acta oncologica1 citations Open access
Semantic Scholar
Cisplatin and 5-Fluorouracil with or Without Epidermal Growth Factor Receptor Inhibition Panitumumab for Patients with Non-Resectable, Advanced or Metastatic Esophageal Squamous Cell Cancer: A Prospective, Open-Label, Randomised Phase 3 AIO/EORTC Trial (Power)
M. Moehler, A. Maderer, P. Thuss-Patience, B. Brenner +16 more
2019Social Science Research Network1 citations
Semantic Scholar
Survival after secondary liver resection in metastatic colorectal cancer: A comparative analysis of the LICC trial with historical controls (CELIM, FIRE-3).
M. Moehler, G. Folprecht, V. Heinemann, J. Holch +16 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
Sa1909 Predictive Value of Proteins Related With the VEGFR and EGFR Pathways in Patients With Stage II/III Colorectal Cancer Receiving Adjuvant Treatment With Fluorouracil, Leucovorin +/− Irinotecan: Translational Results of the FOGT-4 Trial
T. Thomaidis, A. Maderer, M. Kornmann, S. Bauer +8 more
20141 citations Open access
Semantic Scholar
330TiP Total neoadjuvant treatment (TNT) with or without tislelizumab for locally advanced rectal cancer (LARC): An open-label randomized controlled phase II study (The TOTAL Trial)
B. Brenner, Y. Kundel, A. Ayal, A. Sulkes +15 more
2026Annals of Oncology0 citations Open access
Semantic Scholar
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer
A. Lamarca, A. Maderer, Daniel-Christoph Wagner, M. McNamara +14 more
2026Translational Oncology0 citations Open access
Semantic Scholar
Serum tumor fibrosis markers of peptide fragments from collagens can be used for diagnostics and are prognostic for overall survival in biliary cancer
L. Kaps, M. A. Genc, M. Möhler, S. Grabbe +3 more
2024Zeitschrift für Gastroenterologie - German Journal of Gastroenterology0 citations
Semantic Scholar
Whole transcriptome analysis to reveal epithelial-mesenchymal transition after neoadjuvant therapy with or without additional anti-EGFR treatment: Subgroup analysis of esophageal squamous cell carcinomas of the SAKK 75/08 and the EORTC AIO POWER study.
A. Siebenhüner, T. Ruhstaller, L. Planas-Paz, Katharina Mühlberger +8 more
2024Journal of Clinical Oncology0 citations Open access
Semantic Scholar
The effect of methylglyoxal and glyoxalase-1 metabolism on immune-mediated signaling and overall survival in biliary tract cancer
Maurice Michel, Rebecca Llanes, Dorothee Wolfhard, Dirk A. Ridder +8 more
202440. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber0 citations
Semantic Scholar
Überleben nach sekundärer Resektion von Lebermetastasen beim metastasierten kolorektalen Karzinom: Eine vergleichende Analyse der LICC-Studie mit historischen Kontrollen (CELIM, FIRE-3)
M. Moehler, G. Folprecht, V. Heinemann, J. Holch +16 more
2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology0 citations
Semantic Scholar
Su1129 – Predictive Significance of Endosonographic (EUS) Staging in Locally Advanced Gastric (GC) Or Gastroesophagealjunction (AEG) Adenocarcinoma: Analysis of Data from a Perioperative Aio-Cao Phase Ii Study
V. Sivanathan, T. Thomaidis, M. Stahl, Chris Utz +18 more
2019Gastroenterology0 citations
Semantic Scholar
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program
M. Moehler, Irina Gepfner-Tuma, A. Maderer, P. Thuss-Patience +17 more
2016BMC Cancer0 citations Open access
Semantic Scholar
The paradox of professionalism education: the context of one U.S. medical school's curricular reform
A. Maderer
20160 citations
Semantic Scholar
Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial
T. Thomaidis, A. Maderer, A. Formentini, S. Bauer +12 more
2014Journal of experimental & clinical cancer research : CR0 citations Open access
Semantic Scholar
EL102 – a new strategy for targeting hypoxia-driven cancer
M. Möhler, A. Maderer, K. Göpfert, D. Sauvigny +3 more
20140 citations
Semantic Scholar
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
T. Thomaidis, A. Maderer, S. Al-Batran, J. Kany +8 more
2014BMC Cancer0 citations Open access
Semantic Scholar
Moguntinones—NewSelectiveInhibitorsfortheTreatmentof Human Colorectal Cancer
A. Maderer, S. Plutizki, Jan-Peter Kramb, G. Katrin +7 more
20140 citations
Semantic Scholar
' s response to reviews Title : VEGFR-3 and CXCR 4 as predictive markers for treatment with fluorouracil , leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer : a comparative study of the Arbeitsgemeinschaft
T. Thomaidis, A. Maderer
20120 citations
Semantic Scholar
Tufts University School of Medicine.
M. Blanco, S. Epstein, A. Maderer
2010Academic medicine : journal of the Association of American Medical Colleges0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Moehler×37
Invite
M. Moehler — researcher profile on SciRah
P. Galle×18
Invite
P. Galle — researcher profile on SciRah
T. Thomaidis×13
Invite
T. Thomaidis — researcher profile on SciRah
A. Schad×10
Invite
A. Schad — researcher profile on SciRah

×9

Invite

C. Schimanski — researcher profile on SciRah

P. Thuss-Patience×8

Invite

P. Thuss-Patience — researcher profile on SciRah

S. Al-Batran×7

Invite

S. Al-Batran — researcher profile on SciRah

S. Hegewisch-Becker×6

Invite

S. Hegewisch-Becker — researcher profile on SciRah

Invite

A. Weinmann — researcher profile on SciRah

Invite

M. Lutz — researcher profile on SciRah

Invite

F. Lordick — researcher profile on SciRah

Invite

M. Woerns — researcher profile on SciRah